Clinical Trial: A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Brain Metastases, Adult
Study Type: INTERVENTIONAL
Official Title: A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases
Brief Summary:
The purpose of this study is to determine if the study drug, patritumab deruxtecan (HER3-DXd), can be measured in brain tumor tissue after recieving one dose of patritumab deruxtecan before surgery.
Read more